Welcome to Leukemia

Leading journal covering all aspects of the research and treatment of leukemia and allied diseases.


  • A sincere thank you to all of the reviewers listed here, who took the time to review for Leukemia in 2020. The journal could not exist without the knowledge and critical evaluation provided by our reviewers - content is often vastly improved by the suggestions and recommendations they provide.

  • As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Leukemia is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


Caring for those with haematological disorders during the Covid-19 pandemic

Caring for those with haematological disorders during the Covid-19 pandemic

During this extraordinary time Leukemia is committed to providing research which will help our readers care for people with haematological disorders at risk of SARS-CoV2-infection and COVID-19. We encourage you to submit relevant research or correspondence, which whilst keeping our high standards of quality and accuracy, will be expedited through peer review and rapidly published online. Below is a selection of article already published – more to follow soon. All research featured in this collection will be free to access until the end of the pandemic.